USPTO serial 88425628
UNWIND
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOLFE, YOUNG J
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with UNWIND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Leamington, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter Sloane
Peter Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Bath additives, namely, cosmetic bath salts, bath melts, bath herbs, bubble bath, foam bath, bath bombs, bath gel, bath beads, bath flakes, bath crystals; non-medicated lip care preparations, non-medicated lip conditioners; liquid soaps, namely, non-medicated bath soaps, non-medicated liquid soaps, liquid soaps for laundry; non-medicated skin care preparations; bath oils; bath oils for cosmetic purposes; beauty care cosmetics; beauty creams for body care; beauty gels; beauty lotions; body and beauty care cosmetics; body creams; cosmetic body oils; cosmetic creams; cosmetic oils; cosmetics and make-up; face and body lotions; face and body milk; face lotion; hair care preparations; hair styling preparations; hand cream; hand lotions; non-medicated lip care preparations; non-medicated lip conditioners; lip glosses; massage creams; massage oils; non-medicated bubble bath preparations; non-medicated preparations for the care of hair; non-medicated preparations for the care of skin; non-medicated preparations for the care of the scalp; oils for toiletry purposes; skin creams; skin emollients; skin lotions; skin soap; non-medicated soaps for body care; non-medicated soaps for personal use, namely, cream soaps, bath soaps, bar soaps, paper soaps; all of the foregoing containing ingredients derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD | ACTIVE | — |
| 005 | Bath additives, namely, medicated bath salts containing derivatives of hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; Medicated liquid soaps, disinfectant and anti-bacterial liquid soaps, medicated skin care preparations each containing derivatives of hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; Hemp related products, namely, medicinal oils and therapeutic skin salves each containing derivatives of hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; Concentrated medicated pastes for cleaning the teeth and gums, for treating the hair and scalp, and for use on skin rashes each containing resins and oils derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis; Herbal tinctures and medicinal preparations for the mouth to be applied in the form of tablets and capsules each containing resins and oils derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; Medicated body oils, skin salves, and concentrated skin pastes each containing resins and oils derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; Herbal tinctures and medicinal preparations for the mouth to be applied in the form of tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; Nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; Nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; Medicated topical skin creams, medicated bar and liquid soaps each of the foregoing containing derivatives of hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; Medicated bath additives, namely, bath herbs, bath oils, bath salts each of the foregoing containing derivatives of hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; Medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; Personal sexual lubricants; Transdermal patches containing derivatives of hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; Oral sprays containing cannabidiol with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; Hemp derivatives in the nature of applicant must specify actual product with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for medicinal use; Hemp related products, namely, skin oils derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; Therapeutic body oils derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing containing ingredients derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD | ACTIVE | — |
| 029 | Oils derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; Hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis; Food products containing hemp, cannabidiol, resins and cannabidiol oils, namely, butter derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis; Fruit based energy food bars; seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing containing ingredients derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD | ACTIVE | — |
| 030 | Food products containing hemp and derivatives thereof, namely, chocolates, cookies, brownies, candy and granola-based snack bars, cereal based food energy bars all containing ingredients derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD; Tea, namely, teas containing hemp and derivatives thereof with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD | ACTIVE | — |
| 031 | Live hemp plants with a delta-9 THC concentration of not more than 0.3 percent dry weight basis; Hemp seeds for planting and agricultural use, derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis | ACTIVE | — |
| 032 | Smoothies, fruit beverages and fruit juices, carbonated soft drinks, and energy drinks each containing hemp and derivatives thereof derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD | ACTIVE | — |
| 034 | Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking with a delta-9 THC concentration of not more than 0.3 percent dry weight basis; Derivatives of hemp, namely, processed resins and oils, not being essential oils, derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis in the nature of liquids for use in electronic cigarettes and oral smokeless vaporizers; E-liquids comprised of hemp derivatives not being essential oils, derived from hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis for use in electronic cigarettes and oral smokeless vaporizers for recreational use; Smokers' articles, namely, smoking pipes, oral vaporizers for smokers; all of the foregoing containing hemp or derivatives with a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD or exclusively for use with goods having a delta-9 THC concentration of not more than 0.3 percent dry weight basis and not containing CBD; smokers' articles, namely, pouches for use with hemp with a delta-9 THC concentration of not more than 0.3 percent dry weight basis, lighters for smokers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aphria Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 031
- Other trademarks in Class 032
- Other trademarks in Class 034
- Similar marks named UNWIND
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 28, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 28, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 28, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 28, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 12, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 6, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 19, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 19, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 18, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 25, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 25, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 25, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 28, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 14, 2019 | NWAP | NEW APPLICATION ENTERED | — |